Mandukaparni

<h3> Absolute Contraindications of Mandukaparni (Centella asiatica) </h3> <h4>Pregnancy or actively trying to conceive</h4> <ul> <li> 🤰 <li> Recommendation: Avoid oral Mandukaparni extracts if you are pregnant or trying to conceive; discuss any topical use with your clinician and avoid ingestion during pregnancy. <li> Reasoning: Animal studies show reduced sperm counts, degeneration of spermatogenic cells and other reproductive effects in rodents after systemic exposure-raising concern about reproductive safety until adequate human data exist. <li> Scientific_Study_Title: Antispermatogenic and antifertility effect of Pegaga (Centella asiatica L) on the testis of male Sprague-Dawley rats <li> Scientific_Study_Authors: I Yunianto, S Das, M Mat Noor <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/20589353/ <li> Scientific_Study_Excerpt: <p>The authors treated adult male rats with Centella asiatica extract for 42 days and then examined testicular histology, hormone levels and sperm parameters. Treated groups showed degeneration of spermatogenic cells, reduced spermatozoa in seminiferous tubules, lowered serum testosterone, and significantly decreased cauda epididymal sperm count and motility-especially at medium and high doses. The investigators concluded that Centella asiatica produced antispermatogenic and antifertility effects in this rodent model, suggesting potential reproductive risks with systemic exposure in animals (dose-dependent effects observed).</p> </ul> <h4>Known liver disease or active liver injury</h4> <ul> <li> 🩺🟠 <li> Recommendation: Do not take oral Mandukaparni if you have active liver disease or unexplained liver test abnormalities; stop use and seek medical advice if jaundice or dark urine appear. <li> Reasoning: Rare cases of acute liver injury (jaundice, marked ALT/AST elevations, granulomatous hepatitis) have been reported after oral Centella use; although uncommon, the injury may be clinically significant and appears to resolve on stopping the herb. <li> Scientific_Study_Title: Hepatotoxicity associated with the ingestion of Centella asiatica <li> Scientific_Study_Authors: O A Jorge, A D Jorge <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/15801887/ <li> Scientific_Study_Excerpt: <p>This case report series described three women who developed clinically apparent liver injury after taking oral Centella asiatica for several weeks (onset 3-8 weeks). Laboratory findings included markedly elevated ALT and AST and elevated bilirubin; liver biopsy findings included granulomatous hepatitis and necroinflammatory changes. Symptoms and tests improved after stopping Centella; one patient rechallenged and had recurrence. Authors suggested an idiosyncratic or immune-mediated mechanism linked to triterpenic constituents and recommended stopping the herb when liver injury occurs.</p> </ul> <h4>Known allergy or previous contact hypersensitivity to Centella (topical products)</h4> <ul> <li> ⚠️🧴 <li> Recommendation: Avoid topical or systemic use if you've had a prior rash or positive patch test to Centella products; perform a patch test before first topical use if uncertain. <li> Reasoning: Case reports document allergic contact dermatitis provoked by topical Centella preparations; sensitivity is uncommon but established. <li> Scientific_Study_Title: Allergic contact dermatitis due to Centella asiatica: a new case <li> Scientific_Study_Authors: M A Gonzalo Garijo, F Revenga Arranz, P Bobadilla González <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/8766746/ <li> Scientific_Study_Excerpt: <p>The report describes a patient who developed allergic contact dermatitis after exposure to Centella asiatica preparations. Patch testing at different concentrations and vehicles confirmed sensitization, leading the authors to recommend cautious patch testing and awareness that Centella can act as a weak sensitizer. The manuscript emphasizes that while many tolerate Centella topically, allergic reactions have been documented and should guide clinical choice of topical therapy.</p> </ul> <h3> Relative Contraindications of Mandukaparni (Centella asiatica) </h3> <h4>Concurrent use with drugs metabolized by CYP2C9 (e.g., warfarin, some NSAIDs)</h4> <ul> <li> ⚖️ <li> Interaction Recommendation: Use caution and consult your clinician; if co-use is unavoidable, monitor drug levels/clinical effects (e.g., INR for warfarin) closely. <li> Reasoning: In vitro studies show Centella constituents-particularly asiatic acid and some non-aqueous extracts-can inhibit CYP2C9; this could increase blood concentrations of medications metabolized mainly via CYP2C9. <li> Scientific_Study_Title: In vitro modulatory effects on three major human cytochrome P450 enzymes by multiple active constituents and extracts of Centella asiatica <li> Scientific_Study_Authors: HJ Chan, ZY Chiu, et al. (authors as listed in PubMed record) <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/20457244/ <li> Scientific_Study_Excerpt: <p>This in vitro enzyme kinetics study evaluated active constituents (asiaticoside, asiatic acid, madecassic acid) and multiple Centella extracts against CYP2C9, CYP2D6 and CYP3A4. The authors found that CYP2C9 was most susceptible: asiatic acid produced potent inhibition of CYP2C9 (K(i)=9.1 μg/mL) and some ethanol/dichloromethane extracts also showed moderate inhibition. Asiaticoside showed much weaker effects. The paper concludes that extracts rich in asiatic acid or prepared with certain solvents may pose interaction risk with CYP2C9 substrates.</p> </ul> <h4>Concurrent use with antiepileptic drugs (example: phenytoin, valproate) - caution</h4> <ul> <li> ⚡ <li> Interaction Recommendation: Avoid unsupervised combination; consult your neurologist before adding Mandukaparni to a regimen that includes antiepileptic drugs. <li> Reasoning: Preclinical pharmacokinetic/pharmacodynamic studies show Centella extract altered effects and blood levels of phenytoin and valproate in animal models, suggesting possible interaction that could change seizure control or drug exposure. <li> Scientific_Study_Title: Pharmacodynamic and pharmacokinetic interactions of hydroalcoholic leaf extract of Centella asiatica with valproate and phenytoin in experimental models of epilepsy in rats <li> Scientific_Study_Authors: S. (authors as listed in PubMed record) <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/33429032/ <li> Scientific_Study_Excerpt: <p>In rat seizure models, co-administration of a hydroalcoholic Centella extract with therapeutic and sub-therapeutic doses of valproate or phenytoin modified seizure outcomes and affected pharmacokinetic parameters. The work reported changes in behavioural seizure measures, and the authors discuss that Centella's enzyme-modulating properties and CNS effects could underlie altered antiepileptic drug action-supporting clinical caution for co-administration until human interaction data are available.</p> </ul> <h4>Use with other hepatotoxic agents (e.g., high-dose acetaminophen, isoniazid) - caution advised</h4> <ul> <li> 🧪 <li> Interaction Recommendation: If you take other agents known to affect the liver, avoid adding oral Mandukaparni without medical supervision and monitor liver tests if use is clinically indicated. <li> Reasoning: Although Centella has hepatoprotective evidence in many models, rare human reports of herb-associated liver injury mean combined exposure with other hepatotoxins could complicate causality or increase risk in susceptible individuals. <li> Scientific_Study_Title: Hepatotoxicity associated with the ingestion of Centella asiatica <li> Scientific_Study_Authors: O A Jorge, A D Jorge <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/15801887/ <li> Scientific_Study_Excerpt: <p>The case series documents acute liver injury after Centella ingestion in three individuals; timing (weeks), large enzyme elevations, biopsy findings (granulomatous hepatitis) and improvement after discontinuation suggest a herb-related idiosyncratic injury. The authors note triterpenic constituents might promote apoptosis and immune reactions in rare cases, supporting extra caution when other hepatotoxic drugs are being used concurrently.</p> </ul>